AVBP

ArriVent BioPharma, Inc. Common Stock (AVBP)

US
$ 21.870.28%

Price Chart

Key Statistics

Market Cap
$ 746.02M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
156.11K
52W High
$ 36.37
52W Low
$ 15.47
Dividend Yield
0.00%
Beta
0.00

Technicals

50-Day MA
21.6127
200-Day MA
24.5414
52 Week High
36.37
52 Week Low
15.47

About AVBP

ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancer.

Employees
52
Headquarters
Newtown Square, PA
CEO
Dr. Zhengbin Yao Ph.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
JELD
JELD-WEN Holding In...
$ 4.40
12.24
LVS
Las Vegas Sands Cor...
$ 47.36
8.87
CCS
Century Communities...
$ 61.22
8.70
KTB
Kontoor Brands Inc....
$ 71.65
8.61
BBWI
Bath & Body Works I...
$ 32.40
8.14

Top Losers

Symbol/Name
LTP
% Chg
ACHR
Archer Aviation Inc...
$ 9.97
-8.11
AMC
AMC Entertainment H...
$ 2.87
-7.42
OKLO
Oklo Inc.
$ 52.29
-6.58
QS
QuantumScape Corpor...
$ 6.29
-6.40
SE
Sea Limited America...
$ 150.49
-5.96